MENU
+Compare
MDXG
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$6.78
Change
+$0.02 (+0.30%)
Capitalization
1B

MDXG MiMedx Group Forecast, Technical & Fundamental Analysis

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more

Industry: #Biotechnology
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MDXG with price predictions
Apr 23, 2025

MDXG's RSI Indicator recovers from oversold territory

The RSI Oscillator for MDXG moved out of oversold territory on April 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDXG advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

MDXG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MDXG as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MDXG turned negative on March 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MDXG entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.189) is normal, around the industry mean (14.056). P/E Ratio (24.286) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (2.905) is also within normal values, averaging (252.992).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

View a ticker or compare two or three
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MDXG is expected to report earnings to fall 17.86% to 5 cents per share on April 30

MiMedx Group MDXG Stock Earnings Reports
Q1'25
Est.
$0.06
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Est.
$0.08
Q1'24
Beat
by $0.02
The last earnings report on February 26 showed earnings per share of 7 cents, beating the estimate of 5 cents. With 406.85K shares outstanding, the current market capitalization sits at 1.00B.
A.I. Advisor
published General Information

General Information

a manufacturer of patent protected regenerative biomaterial products and bioimplants

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VAFIX25.70N/A
N/A
Invesco American Franchise Y
JHSOX22.39N/A
N/A
JHancock New Opportunities I
CGVVX12.12N/A
N/A
Causeway Global Value Inv
TROCX27.61N/A
N/A
Touchstone Non-US Equity I
AIVBX17.41N/A
N/A
American Funds International Vntg A

MDXG and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
+1.20%
AXON - MDXG
47%
Loosely correlated
+3.82%
VCYT - MDXG
42%
Loosely correlated
+1.08%
OMER - MDXG
41%
Loosely correlated
-2.52%
ARRY - MDXG
39%
Loosely correlated
+0.93%
RAPT - MDXG
38%
Loosely correlated
+5.93%
More